Expression of PD-L1 in Early-Stage Invasive Breast Carcinoma and Its Relation to Tumor-Infiltrating Lymphocytes

OBJECTIVES: Immunotherapeutic targets became one of the promising approaches in breast cancer (BC), especially in advanced stage triple-negative subtype (TNBC). However, the role of programmed cell death ligand 1 (PD-L1) targeting in other BC subtypes, especially in early-stage carcinoma is less exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Nancy H, Abou-Bakr, Amany A, Eissa, Saad, Nassar, Hanan R, Eissa, Tamer S, Mohamed, Ghada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360934/
https://www.ncbi.nlm.nih.gov/pubmed/35345385
http://dx.doi.org/10.31557/APJCP.2022.23.3.1091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360934/
https://www.ncbi.nlm.nih.gov/pubmed/35345385
http://dx.doi.org/10.31557/APJCP.2022.23.3.1091

Ejemplares similares